Table V.
Clinicopathological features | n | LTBP2 expression
|
χ2 | P-value | |
---|---|---|---|---|---|
Low | High | ||||
Age, years | 0.941 | 0.332 | |||
≥60 | 73 | 30 | 43 | ||
<60 | 101 | 49 | 52 | ||
Sex | 2.177 | 0.140 | |||
Male | 120 | 50 | 70 | ||
Female | 54 | 29 | 25 | ||
Histological grade | 0.158 | 0.691 | |||
G1+G2 | 60 | 26 | 34 | ||
G3 | 114 | 53 | 61 | ||
T stage | 7.836 | 0.005 | |||
T1–T2 | 58 | 35 | 23 | ||
T3–T4 | 116 | 44 | 72 | ||
N stage | 4.392 | 0.036 | |||
N0 | 71 | 39 | 32 | ||
N1–N3 | 103 | 40 | 63 | ||
M stage | 7.600 | 0.006 | |||
M0 | 149 | 74 | 75 | ||
M1 | 25 | 5 | 20 | ||
TNM stage | 5.652 | 0.017 | |||
I–II | 102 | 54 | 48 | ||
III–IV | 72 | 25 | 47 |
LTBP2, latent transforming growth factor-β-binding protein 2; T, tumor; N, node; M, metastasis.